Introduction {#s1}
============

Until recently, the assessment of the endometrial-myometrial junctional zone (EMJ) was mainly used on magnetic resonance images (MRI) for the diagnosis of adenomyosis (Hricak et al.,1983). The EMJ can also be visualized on high-resolution transvaginal 2D and 3D ultrasound. However, on ultrasound the EMJ is not always easy to display and there are currently no strict guidelines on how to analyse the EMJ. Only few studies on 3D imaging of the EMJ have been published (Alcazar et al., 2009; Exacoustos et al., 2011; Naftalin et al., 2012). A proper visualization of the EMJ is deemed to be important in the diagnosis of adenomyosis (Bromley et al., 2000; Dueholm, 2006), myometrial invasion in endometrial cancer, the extension of submucous fibroids and the exact character of congenital uterine anomalies (Naftalin et al., 2009). A standardized sonographic evaluation of the EMJ is therefore important in order to study its relevance in such endometrial and myometrial diseases.

Volume Contrast Imaging (VCI) is a technology based on a volume acquisition technique that leads to contrast enhancement and speckle suppression in the two-dimensional ultrasound image. The use of VCI improves the contrast in ultrasound images (Henrich and Stupin, 2011; Jantarasaengaram et al., 2014) and may offer a better assessment of size, margins and aspect of EMJ. VCI is quickly performed and requires less training than 3D rendering.

The aim of this study was to evaluate which 3D reconstruction technique allows for optimal visualization of the EMJ on 3D stored images.

Methods {#s2}
=======

3D volumes from 183 consecutive patients who presented at the Leuven University Hospital bleeding clinic were selected in decreasing chronological order from 2009-2010 database. The protocol was approved by the local Ethics Committee of the University Hospitals Leuven and patients had given informed consent. The 3D volumes were collected using a Voluson E8 (GE Healthcare Ultrasound, Milwaukee, WI, USA) with a 6-12 MHz transvaginal probe. Out of the 183 cases, 65 cases with incomplete data were excluded. Of the remaining 118 3D volumes, the first author scored the image quality of the EMJ, for each reconstructed image without the use of VCI, as good (the EMJ is clearly visible and can be evaluated on the fundal, right lateral and left lateral borders), moderate (one border is not clearly visible), poor (two borders are not clearly visible) or insufficient (none of the borders are clearly visible). After exclusion of 38 cases because of insufficient image quality, 80 patients (study group) were selected for further analysis.

For each 3D volume, the uterus was examined in the sagittal plane to identify the cervical canal and the uterine cavity, and after complete rotation of 360°, the first author reconstructed the best image on 2D midcoronal plane without VCI, with VCI set at 4 mm and with VCI set at 2 mm.

The coronal view was obtained by placing the dot into the endometrial stripe on the sagittal and transverse views (plane A and B of the multiplanar view). The multiplanar view was then adjusted until a satisfactory coronal image was obtained of both the endometrial cavity and the external uterine contour. The gradient light and sepia settings were used to optimize the view of the EMJ, which was visualized as a hypoechoic area surrounding the endometrial cavity.

For each 3D volume, 3 images in the coronal plane were reconstructed (2D coronal plane without VCI, with VCI 4 mm and VCI 2 mm), resulting in 240 images. Together with a questionnaire pertaining to these images, they were integrated into the web-based electronic data capture software Clinical Data Miner (CDM) (Installé et al., 2014) (<http://cdm.esat.kuleuven.be>).

Five gynaecologists with experience in gynaecological ultrasound used CDM to evaluate the questionnaire for all images, which were shown in random order to each examiner. The questionnaire comprised two questions.

In the first question, examiners reported image quality as good, moderate, poor, or insufficient, encoded as 4, 3, 2, and 1, respectively. These values were then averaged for the different technologies. Significance of differences in reported quality for the different technologies were assessed using paired t-tests.

In the second question, examiners assessed the EMJ of these images using IETA terminology (Leone et al., 2010), as regular, irregular, interrupted, or not defined, with one examiner (CVP) re-evaluating the same set of images after 12 days. These evaluations were used to calculate both inter- and intra-rater agreement, by means of Fleiss' kappa coefficient (Fleiss et al., 1971). The jackknife technique was used to determine confidence intervals for the kappa coefficient values.

Results {#s3}
=======

Compared to the coronal view without VCI, the use of both 4 mm and 2 mm VCI improved subjective image quality reported by participants (p \< 0.001).

The Fleiss' kappa coefficient for evaluating the inter-rater agreement of the EMJ description using coronal view without VCI, with VCI at 4 mm and VCI at 2 mm were 0.36 ± 0.05, 0.34 ± 0.05 and 0.42 ± 0.05, respectively.

The corresponding figures for the intra-rater agreement for EMJ were 0.58 ± 0.08, 0.36 ± 0.08 and 0.68 ± 0.07, respectively. The use of VCI 2 mm improved inter-rater and intra-rater agreement of EMJ description (p \< 0.001), while VCI 4 mm did not.

Discussion {#s4}
==========

This study demonstrates that the visualization of the EMJ in the coronal plane using VCI 2 mm outperforms VCI 4 mm and 2D coronal plane without VCI. Using thicker VCI slices causes blurring, deteriorating the image quality (Fig. 1). Likewise, if 3D-rendering is used, the best images of the EMJ will be obtained using a thin region of interest (ROI) box (Fig. 2).

![Coronal plane without Volume Contrast Imaging (VCI), with VCI 2 mm, VCI 4 mm, VCI 8 mm and VCI 12 mm. Note that using thicker VCI slices causes blurring, deteriorating the image quality.\
Upper row: regular endometrial-myometrial junction.\
Lower row: patient with adenomyosis. Note the irregular endometrial-myometrial junction (especially in the fundus).](FVVinObGyn-7-60-63-g001){#F1}

![3D-rendering of the endometrial-myometrial junction (EMJ) in a normal uterus (top three images) and in a patient with adenomyosis (bottom image): a thin region of interest (ROI) box is chosen. To enhance the image quality the green line can be bent to make the ROI box even thinner (ROI box with concave green line). If the ROI box is made thicker (ROI box with convex green line) the borders of the EMJ become blurred. In the adenomyosis case (bottom): note the irregular endometrial-myometrial junction (especially in de fundus) and the difference in image quality between the C-plane (2D without VCI) and the rendered 3D image.](FVVinObGyn-7-60-63-g002){#F2}

Exacoustos et al., 2011) proposed the use of VCI 2 and 4 mm in the evaluation of the EMJ. Additionally, we have shown that the image quality of VCI 2 mm is superior to that of VCI 4 mm.

Naftalin et al., 2012) studied the inter- and intra-rater agreement in three-dimensional ultrasound assessment of the EMJ. They scored the quality of visualization of the EMJ by coronal view obtained using render mode as optimal, satisfactory or unsatisfactory. Their results showed good inter- and intra-rater variability with kappa values of 0.77 and 0.83 respectively. In our study the results using VCI 2 mm were 0.42 and 0.68, respectively. These differences may be explained by the fact Naftalin et al., 2012) tested 30 volumes of normal uteri only. Moreover our study addressed the issue of the clinical relevance by evaluating the inter- and intra-rater agreement in reporting the EMJ according to the IETA terminology (Leone et al., 2010).

The use of a standardized technique facilitates the dialogue between different observers and allows to evaluate the diagnostic relevance of ultrasound images of the EMJ, e.g. in the evaluation of adenomyosis, endometrial cancer, fibroids and congenital uterine anomalies. We propose to use VCI 2 mm in future studies evaluating the EMJ.
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